Literature DB >> 21338652

One-year chronic oral toxicity with combined reproduction toxicity study of a novel probiotic, Bacillus coagulans, as a food ingredient.

J R Endres1, I Qureshi, T Farber, J Hauswirth, G Hirka, I Pasics, A G Schauss.   

Abstract

Some strains of Bacillus coagulans can survive extremes of heat, stomach acid and bile acids, to which commonly consumed probiotics are susceptible. A toxicological safety assessment was published in 2009 on a proprietary preparation of B. coagulans - GanedenBC(30)™ - a novel probiotic. It was concluded that GanedenBC(30)™ is safe for chronic human consumption based upon scientific procedures, supported by a safe history of use (Endres et al., 2009). A one-year chronic oral toxicity study combined with a one-generation reproduction study was conducted to further investigate safety of long-term consumption. The one-year study of GanedenBC(30)™ administered to male and female HsdBrlHan: Wistar rats in their diet showed no signs of toxicity at the highest dose tested. The conclusion from the reproduction toxicity study is that administration of GanedenBC(30)™ in the diet caused no signs of toxicity in the parental generation (male or female) nor the F1 offspring. Using the lowest NOEL of 1948 mg/kg concluded at the end of the 1-year feeding study, a 100-fold safety factor, a test article concentration of 6.88×10(10) CFU (colony forming units) per gram, and an average 70 kg human, it is determined that GanedenBC(30)™ is safe for chronic consumption at up to 9.38×10(10) CFUs per day.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21338652     DOI: 10.1016/j.fct.2011.02.012

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Structure and dynamics of the bacterial communities in fermentation of the traditional Chinese post-fermented pu-erh tea revealed by 16S rRNA gene clone library.

Authors:  Ming Zhao; Wei Xiao; Yan Ma; Tingting Sun; Wenxia Yuan; Na Tang; Donglian Zhang; Yongxia Wang; Yali Li; Hongjie Zhou; Xiaolong Cui
Journal:  World J Microbiol Biotechnol       Date:  2013-04-17       Impact factor: 3.312

2.  Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.

Authors:  Otto O Yang; Theodoros Kelesidis; Robert Cordova; Homayoon Khanlou
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-11       Impact factor: 1.723

3.  Effect of oral administration of Bacillus coagulans B37 and Bacillus pumilus B9 strains on fecal coliforms, Lactobacillus and Bacillus spp. in rat animal model.

Authors:  Lopamudra Haldar; D N Gandhi
Journal:  Vet World       Date:  2016-07-26

4.  Effect of Bacillus coagulans SNZ 1969 on the Improvement of Bowel Movement in Loperamide-Treated SD Rats.

Authors:  Soo-Min Jung; Ae-Wha Ha; Su-Jin Choi; Se-Young Kim; Woo-Kyoung Kim
Journal:  Nutrients       Date:  2022-09-08       Impact factor: 6.706

5.  Complete Genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, Two Phylogenetically Distinct Probiotics.

Authors:  Indu Khatri; Shailza Sharma; T N C Ramya; Srikrishna Subramanian
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

Review 6.  Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization.

Authors:  Ralf Jäger; Martin Purpura; Sean Farmer; Howard A Cash; David Keller
Journal:  Probiotics Antimicrob Proteins       Date:  2018-12       Impact factor: 4.609

Review 7.  Application of Bacillus coagulans in Animal Husbandry and Its Underlying Mechanisms.

Authors:  Yuanhao Zhou; Zihan Zeng; Yibin Xu; Jiafu Ying; Baikui Wang; Muhammed Majeed; Shaheen Majeed; Anurag Pande; Weifen Li
Journal:  Animals (Basel)       Date:  2020-03-09       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.